These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15032546)

  • 21. Computational aqueous solubility prediction for drug-like compounds in congeneric series.
    Du-Cuny L; Huwyler J; Wiese M; Kansy M
    Eur J Med Chem; 2008 Mar; 43(3):501-12. PubMed ID: 17574307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GLARE: a new approach for filtering large reagent lists in combinatorial library design using product properties.
    Truchon JF; Bayly CI
    J Chem Inf Model; 2006; 46(4):1536-48. PubMed ID: 16859286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High throughput microsomal stability assay for insoluble compounds.
    Di L; Kerns EH; Li SQ; Petusky SL
    Int J Pharm; 2006 Jul; 317(1):54-60. PubMed ID: 16621364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.
    Bergström CA
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):156-61. PubMed ID: 15733209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives.
    Remko M; Swart M; Bickelhaupt FM
    Bioorg Med Chem; 2006 Mar; 14(6):1715-28. PubMed ID: 16263295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery.
    Yu S; Li S; Yang H; Lee F; Wu JT; Qian MG
    Rapid Commun Mass Spectrom; 2005; 19(2):250-4. PubMed ID: 15609367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés".
    Lameijer EW; Kok JN; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):553-62. PubMed ID: 16562983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
    Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
    ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated compound verification using 2D-NMR HSQC data in an open-access environment.
    Keyes P; Hernandez G; Cianchetta G; Robinson J; Lefebvre B
    Magn Reson Chem; 2009 Jan; 47(1):38-52. PubMed ID: 18991323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview on the Rule of Five.
    Pollastri MP
    Curr Protoc Pharmacol; 2010 Jun; Chapter 9():Unit 9.12. PubMed ID: 22294375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
    Evers A; Klabunde T
    J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular properties that influence oral drug-like behavior.
    Lajiness MS; Vieth M; Erickson J
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):470-7. PubMed ID: 15338956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro models for the blood-brain barrier.
    Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
    Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case histories in drug discovery and design.
    SMR Committee
    Drug News Perspect; 1998 Feb; 11(1):52-7. PubMed ID: 15616642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds.
    Marino AM; Yarde M; Patel H; Chong S; Balimane PV
    Int J Pharm; 2005 Jun; 297(1-2):235-41. PubMed ID: 15907606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A consensus neural network-based technique for discriminating soluble and poorly soluble compounds.
    Manallack DT; Tehan BG; Gancia E; Hudson BD; Ford MG; Livingstone DJ; Whitley DC; Pitt WR
    J Chem Inf Comput Sci; 2003; 43(2):674-9. PubMed ID: 12653537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.